Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.

Levin ED, Wells C, Johnson JE, Rezvani AH, Bymaster FP, Rose JE.

Eur J Pharmacol. 2015 Oct 5;764:30-7. doi: 10.1016/j.ejphar.2015.06.041. Epub 2015 Jun 20.

2.

Striatal cholinergic interneuron regulation and circuit effects.

Lim SA, Kang UJ, McGehee DS.

Front Synaptic Neurosci. 2014 Oct 21;6:22. doi: 10.3389/fnsyn.2014.00022. eCollection 2014. Review.

3.

Subunit composition of α5-containing nicotinic receptors in the rodent habenula.

Scholze P, Koth G, Orr-Urtreger A, Huck S.

J Neurochem. 2012 May;121(4):551-60. doi: 10.1111/j.1471-4159.2012.07714.x. Epub 2012 Mar 20.

4.

α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Quik M, Wonnacott S.

Pharmacol Rev. 2011 Dec;63(4):938-66. doi: 10.1124/pr.110.003269. Review.

5.

Specific α4β2 nicotinic acetylcholine receptor binding of [F-18]nifene in the rhesus monkey.

Hillmer AT, Wooten DW, Moirano JM, Slesarev M, Barnhart TE, Engle JW, Nickles RJ, Murali D, Schneider ML, Mukherjee J, Christian BT.

Synapse. 2011 Dec;65(12):1309-18. doi: 10.1002/syn.20965. Epub 2011 Aug 31.

6.

Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.

Caldarone BJ, Wang D, Paterson NE, Manzano M, Fedolak A, Cavino K, Kwan M, Hanania T, Chellappan SK, Kozikowski AP, Olivier B, Picciotto MR, Ghavami A.

Psychopharmacology (Berl). 2011 Sep;217(2):199-210. doi: 10.1007/s00213-011-2271-y. Epub 2011 Apr 13.

7.

α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion.

Scholze P, Ciuraszkiewicz A, Groessl F, Orr-Urtreger A, McIntosh JM, Huck S.

Dev Neurobiol. 2011 May;71(5):390-9. doi: 10.1002/dneu.20870.

8.

Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes.

David R, Ciuraszkiewicz A, Simeone X, Orr-Urtreger A, Papke RL, McIntosh JM, Huck S, Scholze P.

Eur J Neurosci. 2010 Mar;31(6):978-93. doi: 10.1111/j.1460-9568.2010.07133.x. Epub 2010 Mar 3.

9.

Phantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyi.

Fitch RW, Spande TF, Garraffo HM, Yeh HJ, Daly JW.

J Nat Prod. 2010 Mar 26;73(3):331-7. doi: 10.1021/np900727e.

10.

Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.

Henningfield JE, Shiffman S, Ferguson SG, Gritz ER.

Pharmacol Ther. 2009 Jul;123(1):1-16. doi: 10.1016/j.pharmthera.2009.03.011. Epub 2009 Apr 8. Review.

11.

The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Grady SR, Salminen O, Laverty DC, Whiteaker P, McIntosh JM, Collins AC, Marks MJ.

Biochem Pharmacol. 2007 Oct 15;74(8):1235-46. Epub 2007 Jul 27. Review.

12.

Cognitive deficits in schizophrenia: focus on neuronal nicotinic acetylcholine receptors and smoking.

Ochoa EL, Lasalde-Dominicci J.

Cell Mol Neurobiol. 2007 Aug;27(5):609-39. Review.

13.

Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons.

Azam L, Chen Y, Leslie FM.

Neuroscience. 2007 Feb 23;144(4):1347-60. Epub 2006 Dec 29.

14.
15.

Supplemental Content

Support Center